What's breaking now, across thousands of outlets.
After a whirlwind third quarter that saw two FDA approvals but a major setback in Angelman syndrome, Ultragenyx is laying off staff for the second time this year. The California biopharma
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- The regulatory status of a low-dose atropine eye drop formulation for myopia remained unresolved following a day-long FDA advisory committee meeting, but closing comments did not…
Learn why certain “unhealthy” diets seemed to boost cancer immunotherapy in mice and how it’s related to the gut microbiome.
A psychologist explains in a Cleveland Clinic guide how burnout shows up in body and mood, how it differs from depression, and how to recover.
Learn how the spread of H5N1 avian influenza among dairy farms in Washington State led to the first human bird flu death in the U.S. in 2026.
Our neighbour's bonfires set off my asthma every year. I've told him, but he hasn't stopped. Can I force him to?
